Vertex Pharmaceuticals (VRTX)

Investing Cash Flow

-$45.80M

Quarterly · Period ending: · USD

VRTX logo

VRTX Investing Cash Flow

Latest reported-$45.80M
VRTX Quarterly Cash from Investing (-$20.10M → -$45.80M)
High-resolution chart · PNG

VRTX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-45,800,000
-431,900,000
-288,100,000
-117,000,000
-484,500,000
-55,800,000
-821,900,000
-348,000,000
-463,700,000
-2,136,400,000
-886,500,000
-117,700,000
-303,900,000
-1,833,600,000
175,600,000
-384,200,000
-61,500,000
-51,000,000
-133,998,000
-52,952,000
-79,641,000
-74,309,000
243,747,000
-247,937,000
71,912,000
31,666,000
-896,991,000
-248,999,000
-50,190,000
-39,138,000
-40,904,000
-49,889,000
-116,298,000
4,933,000
-21,097,000
-162,456,000
-96,347,000
-157,781,000
230,168,000
34,791,000
-57,782,000
-102,708,000
-122,690,000
-100,935,000
278,443,000
214,038,000
-26,061,000
30,545,000
89,882,000
-20,407,000
-61,379,000
49,536,000
-4,691,000
-37,596,000
7,156,000
-131,228,000
-70,043,000
-231,702,000
-387,776,000
21,446,000
172,790,000
405,952,000
-169,695,000
-2,414,000
40,648,000
138,762,000
-547,777,000
42,525,000
-83,657,000
80,177,000
-70,515,000
-103,857,000
-34,874,000
-151,404,000
143,735,000
181,261,000
-125,495,000
205,665,000
-280,301,000
20,712,000
8,830,000
42,288,000
-32,064,000
-48,385,000
42,012,000
36,705,000
37,891,000
18,142,000
44,757,000
6,638,000
32,284,000
-16,359,000
-8,176,000
111,836,000
11,202,000
-4,381,000
-38,656,000
15,873,000
-32,228,000
39,268,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.